Page last updated: 2024-10-31

nafamostat and Anterior Cerebral Circulation Infarction

nafamostat has been researched along with Anterior Cerebral Circulation Infarction in 1 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Research Excerpts

ExcerptRelevanceReference
"NM treatment attenuated the brain infarct volume and the loss of body weight and improved the recovery of sensorimotor and cognitive functions."5.46Nafamostat Mesilate Improves Neurological Outcome and Axonal Regeneration after Stroke in Rats. ( Fang, Y; Li, C; Liao, H; Liu, Y; Sun, H; Tao, X; Wang, J; Zhou, XF, 2017)
"NM treatment attenuated the brain infarct volume and the loss of body weight and improved the recovery of sensorimotor and cognitive functions."1.46Nafamostat Mesilate Improves Neurological Outcome and Axonal Regeneration after Stroke in Rats. ( Fang, Y; Li, C; Liao, H; Liu, Y; Sun, H; Tao, X; Wang, J; Zhou, XF, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, Y1
Li, C1
Wang, J1
Fang, Y1
Sun, H1
Tao, X1
Zhou, XF1
Liao, H1

Other Studies

1 other study available for nafamostat and Anterior Cerebral Circulation Infarction

ArticleYear
Nafamostat Mesilate Improves Neurological Outcome and Axonal Regeneration after Stroke in Rats.
    Molecular neurobiology, 2017, Volume: 54, Issue:6

    Topics: Animals; Axons; Benzamidines; Body Weight; Brain Infarction; Cognition; Cyclic AMP Response Element-

2017